![Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis - The Lancet Healthy Longevity Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis - The Lancet Healthy Longevity](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/bc2a7bc6-e60c-489d-86b1-5e1b619fb435/gr1_lrg.jpg)
Frailty measurement, prevalence, incidence, and clinical implications in people with diabetes: a systematic review and study-level meta-analysis - The Lancet Healthy Longevity
![PDF) Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study) PDF) Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study)](https://i1.rgstatic.net/publication/319286258_Effectiveness_of_Vildagliptin_in_Clinical_Practice_Pooled_Analysis_of_Three_Korean_Observational_Studies_the_VICTORY_Study/links/59a0a8d9a6fdcc1a31483def/largepreview.png)
PDF) Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study)
![Joanna Buscemi on Twitter: "New paper alert! We calculated 1) diabetes mortality rates in the 30 largest US cities; 2) Black/white mortality rate ratios/differences; 3) changes in mortality rates & inequities across Joanna Buscemi on Twitter: "New paper alert! We calculated 1) diabetes mortality rates in the 30 largest US cities; 2) Black/white mortality rate ratios/differences; 3) changes in mortality rates & inequities across](https://pbs.twimg.com/media/EtY8ykzUUAIsrdV.jpg:large)
Joanna Buscemi on Twitter: "New paper alert! We calculated 1) diabetes mortality rates in the 30 largest US cities; 2) Black/white mortality rate ratios/differences; 3) changes in mortality rates & inequities across
![Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS) | SpringerLink Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-021-05406-6/MediaObjects/125_2021_5406_Figb_HTML.png)
Screening, prevalence, treatment and control of kidney disease in patients with type 1 and type 2 diabetes in low-to-middle-income countries (2005–2017): the International Diabetes Management Practices Study (IDMPS) | SpringerLink
![PDF) High altitude is not a risk factor for type 2 diabetes mellitus | Sheila Torre Cárdenas - Academia.edu PDF) High altitude is not a risk factor for type 2 diabetes mellitus | Sheila Torre Cárdenas - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51671389/mini_magick20190124-10488-1n2w725.png?1548384674)
PDF) High altitude is not a risk factor for type 2 diabetes mellitus | Sheila Torre Cárdenas - Academia.edu
![Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016) | Scientific Reports Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016) | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-13379-z/MediaObjects/41598_2017_13379_Fig1_HTML.jpg)